4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000062
Chief Medical Officer sold 11,366 shares at $15.29 ($173,774)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-05-14 | Sale 10b5-1 | −11,366 | $15.29 | $173,774 | 106,669 | D |
| Open-market sales · 11,366 sh · avg $15.29 · $173,774 | |||||||
Loading xslF345X05/wk-form4_1747350094.xml…